CD14 and inflammatory bowel disease: Differentiation of CD14+ monocytes to regulatory CD206+ M2 type macrophages, mediated through Fcγ-Receptor signaling, is part of the mechanism of action of anti-TNF mAbs in IBD (11, 13, 14).